Serial Number | 79352347 |
Word Mark | LCLNP |
Filing Date | Monday, July 18, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 28, 2024 |
Registration Number | 7393905 |
Registration Date | Tuesday, May 28, 2024 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 12, 2024 |
Goods and Services | Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging |
Goods and Services | Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 14, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 14, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | NanoVation Therapeutics Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | CA |
Party Name | NanoVation Therapeutics Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | CA |
Party Name | NanoVation Therapeutics Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | CA |
Event Date | Event Description |
Thursday, October 13, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, October 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 18, 2022 | APPLICATION FILING RECEIPT MAILED |
Saturday, March 11, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, May 2, 2023 | ASSIGNED TO EXAMINER |
Friday, June 2, 2023 | NON-FINAL ACTION WRITTEN |
Saturday, June 3, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, July 11, 2023 | REFUSAL PROCESSED BY MPU |
Tuesday, July 11, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, August 1, 2023 | REFUSAL PROCESSED BY IB |
Monday, January 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, January 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, January 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, February 7, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, February 7, 2024 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, February 7, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, February 7, 2024 | EXAMINER'S AMENDMENT ENTERED |
Thursday, February 8, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, February 21, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, February 21, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Monday, March 11, 2024 | NOTIFICATION PROCESSED BY IB |
Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, March 13, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, March 13, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Tuesday, May 28, 2024 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, May 28, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Monday, April 1, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |